Feasibility of guided internet-based cognitive behavioral therapy for patients with anorexia nervosa.
Anorexia nervosa
Clinical trial
Cognitive behavioral therapy
Feasibility study
Internet-based intervention
Journal
Internet interventions
ISSN: 2214-7829
Titre abrégé: Internet Interv
Pays: Netherlands
ID NLM: 101631612
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
17
06
2021
revised:
03
02
2022
accepted:
09
02
2022
entrez:
8
3
2022
pubmed:
9
3
2022
medline:
9
3
2022
Statut:
epublish
Résumé
The objective of the present study was to investigate the feasibility of guided internet cognitive behavioral therapy (ICBT) for anorexia nervosa. We conducted a prospective single-arm study between January 2020 and March 2021. The intervention was built using videos, web programs, and chat tools. The intervention program was largely based on metacognitive training. Participants performed the self-help program once a week for 12 consecutive weeks. The primary outcome was the global Eating Disorder Examination Questionnaire (EDE-Q) score. Secondary outcomes included clinical symptoms of eating disorders, metacognitive function, body mass index, depression, and generalized anxiety. The main statistical analysis examined whether the EDE-Q score and other outcomes at the end of the intervention differed from the baseline. Fourteen participants underwent the trial treatment, and 13 completed the intervention. There was a significant reduction in the global EDE-Q score from 3.48 ( Our findings suggest that guided ICBT for anorexia nervosa is well accepted by female patients and practical as a telemedicine approach that improves symptoms. In the future, tightly controlled randomized controlled trials should be conducted for efficacy verification.
Identifiants
pubmed: 35257002
doi: 10.1016/j.invent.2022.100504
pii: S2214-7829(22)00011-2
pmc: PMC8897312
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100504Informations de copyright
© 2022 The Authors.
Déclaration de conflit d'intérêts
None.
Références
Eur Eat Disord Rev. 2017 Nov;25(6):491-500
pubmed: 28799287
Curr Psychiatry Rep. 2016 Jan;18(1):2
pubmed: 26689208
Obesity (Silver Spring). 2008 Sep;16(9):2024-38
pubmed: 19186327
Int J Eat Disord. 2013 Jul;46(5):516-21
pubmed: 23658103
N Engl J Med. 1999 Apr 8;340(14):1092-8
pubmed: 10194240
Curr Opin Psychiatry. 2017 Nov;30(6):423-437
pubmed: 28777107
Health Econ. 2002 Jun;11(4):341-53
pubmed: 12007165
J Med Internet Res. 2015 Jun 18;17(6):e152
pubmed: 26088580
Endocr Metab Immune Disord Drug Targets. 2018;18(4):316-324
pubmed: 29437020
Curr Opin Psychiatry. 2013 Nov;26(6):543-8
pubmed: 24060914
J Eat Disord. 2015 Dec 01;3:45
pubmed: 26629344
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Am J Psychiatry. 1995 Jul;152(7):1073-4
pubmed: 7793446
Int J Eat Disord. 2017 Mar;50(3):170-189
pubmed: 28102908
Int J Eat Disord. 2018 Aug;51(8):798-821
pubmed: 30102781
World Psychiatry. 2014 Oct;13(3):288-95
pubmed: 25273302
BMC Med. 2017 Jan 17;15(1):12
pubmed: 28095833
Int J Eat Disord. 1994 Dec;16(4):363-70
pubmed: 7866415
Science. 1998 May 29;280(5368):1387-90
pubmed: 9603723
J Med Internet Res. 2015 Mar 31;17(3):e85
pubmed: 25840591
Neuropsychiatr Dis Treat. 2016 Oct 05;12:2527-2531
pubmed: 27785029
J Eat Disord. 2015 Jul 04;3:24
pubmed: 26146555
Behav Res Ther. 2004 Apr;42(4):385-96
pubmed: 14998733
Curr Opin Psychiatry. 2016 Nov;29(6):340-5
pubmed: 27662598
Int J Eat Disord. 2013 Sep;46(6):634-8
pubmed: 23712500
Int J Eat Disord. 2015 Mar;48(2):223-9
pubmed: 24648335
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Behav Res Ther. 2017 Feb;89:41-48
pubmed: 27863331
Int J Eat Disord. 2018 Dec;51(12):1303-1311
pubmed: 30584663
Int J Eat Disord. 2014 Mar;47(2):174-80
pubmed: 24488838
Curr Psychiatry Rep. 2015 Mar;17(3):551
pubmed: 25663154
JAMA Psychiatry. 2014 Oct;71(10):1103-11
pubmed: 25103718
JAMA Psychiatry. 2019 Jul 1;76(7):700-707
pubmed: 30994877
Lancet. 2003 Feb 1;361(9355):407-16
pubmed: 12573387
Eval Program Plann. 1982;5(3):233-7
pubmed: 10259963
Br J Psychiatry. 1998 Jul;173:11-53
pubmed: 9850203
Psychother Res. 2013;23(3):333-43
pubmed: 23088433
Psychol Med. 2017 Dec;47(16):2823-2833
pubmed: 28552083
Cognit Ther Res. 2012 Oct 1;36(5):427-440
pubmed: 23459093
Biopsychosoc Med. 2017 Apr 4;11:9
pubmed: 28392830
Qual Life Res. 2021 Mar;30(3):647-673
pubmed: 33284428
J Med Internet Res. 2018 Dec 17;20(12):e12091
pubmed: 30559094
Am J Psychiatry. 2003 Feb;160(2):242-7
pubmed: 12562569
CNS Drugs. 2006;20(8):655-63
pubmed: 16863270
Cogn Behav Ther. 2018 Jan;47(1):1-18
pubmed: 29215315
Psychol Rep. 2007 Dec;101(3 Pt 1):952-60
pubmed: 18232454
Psychol Med. 2011 Dec;41(12):2581-91
pubmed: 21733215
Clin Psychol Rev. 2014 Feb;34(1):54-72
pubmed: 24394285
Psychol Med. 2013 Dec;43(12):2477-500
pubmed: 23217606
Am J Psychiatry. 2007 Aug;164(8):1259-65
pubmed: 17671290
BMC Psychiatry. 2007 Apr 19;7:13
pubmed: 17442125
Curr Psychiatry Rep. 2016 Apr;18(4):36
pubmed: 26893234
Cortex. 1978 Jun;14(2):234-44
pubmed: 679704
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
J Consult Clin Psychol. 2015 Dec;83(6):1108-22
pubmed: 26302248
Int J Eat Disord. 2002 Apr;31(3):324-33
pubmed: 11920995
J Psychiatr Res. 1985;19(2-3):493-508
pubmed: 3862842